Cyproterone Acetate and Risk of Meningioma: A Nationwide Cohort Study

    June 2021 in “ Journal of neurology, neurosurgery and psychiatry ”
    A. B. Mikkelsen, Iben Katinka Greiber, Nikolai Madrid Scheller … Øjvind Lidegaard
    Studysummary This study found that females exposed to high cumulative doses of cyproterone acetate had a 6–20 fold increased risk of developing meningiomas compared to those on lower doses.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jnnp.bmj.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Use of High-Dose Cyproterone Acetate and Risk of Intracranial Meningioma in Women: Cohort Study BMJ · 2021